Over 6 million Americans have Alzheimer's Disease or Related Dementia (ADRD) but whether spikes in spending surrounding a new diagnosis reflect pre‐diagnosis morbidity, diagnostic testing, or treatments for comorbidities is unknown. Click to show full abstract
Over 6 million Americans have Alzheimer's Disease or Related Dementia (ADRD) but whether spikes in spending surrounding a new diagnosis reflect pre‐diagnosis morbidity, diagnostic testing, or treatments for comorbidities is unknown.
               
Click one of the above tabs to view related content.